The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
17 reports and counting
Baselayer Raises $35M Series A for Agent Identity Infrastructure
Baselayer raised a $35 million Series A led by M13 and launched identity and fraud infrastructure for autonomous agents.
Viabot Raises $24M Series A for Outdoor Property-Care Robotics
Viabot raised a $24 million Series A led by Walden International to scale autonomous robotics for commercial property care.
Novartis Headquarters - Office Location & Address
Discover Novartis's headquarters at Lichtstrasse 35, Basel 4056. Pharmaceutical company. Learn about the office facilities and work environment.
Syngenta Headquarters - Office Location & Address
Discover Syngenta's headquarters at Schwarzwaldallee 215, Basel, 4058. Crop protection and seeds. Learn about the office facilities and work environment.
Roche Headquarters - Office Location & Address
Discover Roche's headquarters at Grenzacherstrasse 124, Basel 4070. Pharmaceutical and diagnostics company. Learn about the office facilities and work environment.
Panalpina Headquarters - Office Location & Address
Discover Panalpina's headquarters at Viaduktstrasse 42, Basel, 4002. Freight forwarding and logistics services. Learn about the office facilities and work environment.
Electra Therapeutics Raises $183 Million in Series C - October 22, 2024
Electra Therapeutics announced $183 Million in Series C funding at a Undisclosed valuation. Electra Therapeutics raised an oversubscribed $183 million Series C to advance clinical trials for novel immunology therapies targeting autoimmune and...
Roche Raises $280B in Public
Roche, a Pharmaceuticals company based in Grenzacherstrasse 124, Basel 4070, Switzerland, has raised $280B in Public at a $300B valuation led by Public.
Novartis Raises $220B in Public
Novartis, a Pharmaceuticals company based in Lichtstrasse 35, Basel 4056, Switzerland, has raised $220B in Public at a $240B valuation led by Public.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.